Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00538824. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma
ClinicalTrials.gov study NCT00112827. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT02726581. IPD Sharing: Not stated. Countries: 16. Publications: 0.
Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01849783. IPD Sharing: NO. Countries: 1. Publications: 0.
Lenalidomide Plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Phase 1 / 2 Study
ClinicalTrials.gov study NCT01054196. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma
ClinicalTrials.gov study NCT01793051. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety/Efficacy Study of LDE225 (Sonidegib) Plus Bortezomib in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02254551. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MEDI-551 as Maintenance Therapy After Allogeneic Stem Cell Transplant in Multiple Myeloma
ClinicalTrials.gov study NCT03218163. IPD Sharing: NO. Countries: 1. Publications: 0.
International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
ClinicalTrials.gov study NCT05669989. IPD Sharing: YES. Countries: 17. Publications: 0.
Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT00258206. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I: Melphalan, Bendamustine and Carfilzomib for Autologous Transplant in Multiple Myeloma
ClinicalTrials.gov study NCT02148913. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM)
ClinicalTrials.gov study NCT01782963. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00464178. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Follow-up of Breast Cancer and Multiple Myeloma Patients Previously Enrolled in NIH Gene Therapy Studies
ClinicalTrials.gov study NCT00427726. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple Myeloma
ClinicalTrials.gov study NCT00560352. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Oprozomib and Dexamethasone,in Combination With Lenalidomide or Oral Cyclophosphamide to Treat Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT01881789. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)
ClinicalTrials.gov study NCT04840680. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of TTI-622 in Combination With Daratumumab Hyaluronidase-fihj in People With Multiple Myeloma
ClinicalTrials.gov study NCT05139225. IPD Sharing: YES. Countries: 1. Publications: 0.
Pembrolizumab, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT03506360. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05172596. IPD Sharing: YES. Countries: 14. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.